$2.31
-0.01-0.43%
Últ. Act.: Nov 19, 6:35 PM

Neuphoria Therapeutics (NEUP) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q1 | Nov 16, 2026 | $-0.26 | $-0.42 | 38.1 % |
| Q4 | Sep 18, 2026 | $-0.95 | $-0.56 | -69.6 % |
| Q3 | May 15, 2026 | $-0.09 | $-0.56 | 83.9 % |
| Q2 | Feb 17, 2026 | $-0.77 | $-0.56 | -37.5 % |
Quarterly Revenue (Billions)
| Metric | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.42 | $-0.56 | $-0.56 | $-0.56 |
| Actual | $-0.26 | $-0.95 | $-0.09 | $-0.77 |
| Surprise | +38.1% | -69.6% | +83.9% | -37.5% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $1.2M | $0 | $0 |
| Surprise | — | — | — | — |